Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Menu
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Issue Briefs
Perspectives
& insights
About us
Show Search
Search Query
Clear
Submit Search
Dictate search request
Listening...
Search Results
No Results
See all results
Sorry, I don't understand. Please try again
Search results
Search Query
Submit Search
Listening...
There are 103 results that match your search.
Transparency
The 340B Program: 2022 Report
Read more
Transparency Report & Issue Briefs
September 1, 2024
2023 Johnson & Johnson Innovative Medicine U.S. pricing transparency report
Creating the next era of healthcare advancements for patients
Read more
Transparency Report & Issue Briefs
July 18, 2025
2024 Pricing Transparency Report: Rebates, discounts and fees by recipient infographic
Read more
Transparency Report & Issue Briefs
July 18, 2025
2024 Pricing Transparency Report: Rebates, discounts and fees infographic
Read more
Access
Influence of Prescription Drug Affordability Boards and Upper Payment Limits on state drug pricing
Read more
Transparency Report & Issue Briefs
July 18, 2025
2024 Pricing Transparency Report: Infographic
Read more
JnJ_TR24_Video01_12-17.mp4
JnJ_TR24_Video01_12-17.mp4
Transparency Report & Issue Briefs
December 19, 2025
Transparency Report Video
Read more
Access
January 27, 2026
Do expedited FDA approvals translate to faster insurance coverage?
Read more
Perspectives & insights
March 6, 2026
Minnesota finds large hospital systems collect most 340B profits, while middlemen siphon off tens of millions
Read more
Perspectives & insights
March 25, 2026
Who’s driving the surge in the 340B Program?
Read more
10 of 11
